2020.03
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer
![1651719823906763.jpg 1.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719823906763.jpg)
![1651719829494595.jpg 2.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719829494595.jpg)
![1651719835661658.jpg 3.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719835661658.jpg)
![1651719840678416.jpg 4.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719840678416.jpg)
![1651719845623693.jpg 5.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719845623693.jpg)
![1651719849172004.jpg 6.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719849172004.jpg)
![1651719854685184.jpg 7.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719854685184.jpg)
![1651719859404669.jpg 8.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719859404669.jpg)
![1651719863834310.jpg 9.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651719863834310.jpg)
Pictures are from Advanced Science.
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma
Characterization of Hyperprogression After Immunotherapy in a Lung Adenocarcinoma Patient With Strong Expression of Programmed Death Ligand 1